CD8+ T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1α and MIP-1β
- 1 April 1997
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 11 (5) , 575-580
- https://doi.org/10.1097/00002030-199705000-00004
Abstract
To assess the role of RANTES, macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta in modulation of HIV-1 long terminal repeat (LTR)-mediated gene expression and determine whether these chemokines share identity with CD8+ T-lymphocyte-derived HIV-1 LTR-suppressive factors. HIV-1 LTR-directed reporter gene expression is a model for transcription that is susceptible to inhibition by factors produced by CD8+ lymphocytes of HIV-1-infected individuals. The effect of recombinant chemokines on LTR-directed gene expression was examined. The ability of chemokines found to be present in CD8 supernatants to suppress HIV-1 LTR-mediated gene expression was determined by antibody inhibition assays. The concentrations of RANTES, MIP-1 alpha and MIP-1 beta in a panel of CD8+ T-lymphocyte-derived supernatants were determined by enzyme-linked immunosorbent assay. Recombinant chemokines were added to freshly transfected (pLTR-CAT and pSV40-tat) human Jurkat T cells. Excessive polyclonal neutralizing antibodies to these chemokines were added to transfected Jurkat T cells cultured in the presence of strongly inhibitory CD8+ T-cell-derived supernatants with known chemokine concentrations. The concentrations of RANTES, MIP-1 alpha and MIP-1 beta in a panel of CD8+ lymphocyte-derived supernatants were found to correlate with their relative ability to suppress the LTR-mediated gene expression (r = 0.679, 0.764 and 0.48, respectively). The addition of recombinant CC chemokines had no effect over a broad range of doses on HIV-1 LTR-mediated gene expression. The CD8-suppressive effect on HIV-1 LTR-driven gene expression was not abrogated by a combination of antibodies of RANTES, MIP-1 alpha and MIP-1 beta. RANTES, MIP-1 alpha and MIP-1 beta do not alter HIV-1 LTR-directed gene expression at doses up to 100 ng/ml. Although present in varying concentrations in supernatants derived from CD8+ lymphocytes from HIV-positive individuals, these chemokines are not responsible for the powerful CD8-derived suppressive effect on HIV-1 LTR-mediated gene expression observed in our system.Keywords
This publication has 25 references indexed in Scilit:
- Suppression of the Human Immunodeficiency Virus Long Terminal Repeat by CD8+T Cells Is Dependent on the NFAT-1 ElementAIDS Research and Human Retroviruses, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Suppression of Activation of the Human Immunodeficiency Virus Long Terminal Repeat by CD8+T Cells Is Not Lentivirus SpecificAIDS Research and Human Retroviruses, 1995
- CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription.Proceedings of the National Academy of Sciences, 1995
- CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine.Proceedings of the National Academy of Sciences, 1994
- Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes.The Journal of Experimental Medicine, 1993
- CD3, CD8 Double-Positive Cells from HIV-1-Infected Chimpanzees Show Group-Specific Inhibition of HIV-1 ReplicationAIDS Research and Human Retroviruses, 1993
- Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from non-human primatesClinical and Experimental Immunology, 1993
- CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency virusesCellular Immunology, 1991
- CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus ReplicationScience, 1986